Sensex
75,502.85 profit arw 938.93 (1.26%)
Nifty
23,408.80 profit arw 257.70 (1.11%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Refresh Captcha
Equity

As on : 13-Mar-2026
Hot Pursuit
13-Mar-2026     10:39

Laurus Labs drops after reports of sharp fall in February export revenue

According to media reports, the pharmaceutical company's export revenue declined 47% to about $36 million in February, reflecting a significant slowdown in overseas sales.

Laurus Labs is a research-driven pharmaceutical and biotechnology company. It holds a leadership position in developing and manufacturing select Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDF) across anti-retroviral, oncology, cardiovascular, and gastro therapeutics.

On a consolidated basis, Laurus Labs net profit rose 172.65% to Rs 251.66 crore while net sales rose 25.67% to Rs 1778.29 crore in Q3 December 2025 over Q3 December 2024.

Powered by Capital Market - Live News

INDIAN INDICES

Sensex

75,502.85 938.93 (1.26%)

Nifty

23,408.80 257.70 (1.11%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

25,834.03 368.42(1.45%)